These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 5720115

  • 1. [Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average].
    Bertrand JJ, Debeyre N, Kahn MF, Ryckewaert A.
    Presse Med (1893); 1968 Nov 23; 76(45):2139-42. PubMed ID: 5720115
    [No Abstract] [Full Text] [Related]

  • 2. [Ocular complications of synthetic antimalarial drugs].
    Bertrand JJ.
    Presse Med (1893); 1968 Nov 23; 76(45):2137-8. PubMed ID: 5720114
    [No Abstract] [Full Text] [Related]

  • 3. On very short wavelength electroretinography. An original technique of diagnosis in infraclinical synthetic antimalarial retinopathies.
    Alfieri R, Sole P.
    Ophthalmologica; 1969 Nov 23; 158 Suppl():661-8. PubMed ID: 5359763
    [No Abstract] [Full Text] [Related]

  • 4. Ocular damage in chloroquine therapy.
    Nylander U.
    Acta Ophthalmol (Copenh); 1967 Nov 23; ():Suppl 92:1-71. PubMed ID: 4866642
    [No Abstract] [Full Text] [Related]

  • 5. Ocular toxicity of antimalarial drugs. Long-term follow-up.
    Carr RE, Henkind P, Rothfield N, Siegel IM.
    Am J Ophthalmol; 1968 Oct 23; 66(4):738-44. PubMed ID: 5729592
    [No Abstract] [Full Text] [Related]

  • 6. Chloroquine retinopathy: evaluation by fluorescein fundus angiography.
    Kearns TP, Hollenhorst RW.
    Trans Am Ophthalmol Soc; 1966 Oct 23; 64():217-31. PubMed ID: 5964922
    [No Abstract] [Full Text] [Related]

  • 7. [Monitoring and prevention of iatrogenic ocular effect in general therapy].
    Le Rebeller MJ, Lanneluc C, Lotte C.
    Annee Ther Clin Ophtalmol; 1981 Oct 23; 32():269-92. PubMed ID: 7348132
    [No Abstract] [Full Text] [Related]

  • 8. [Electroretinography in 83 patients treated with synthetic antimalarials].
    Bertrand JJ.
    Bull Soc Ophtalmol Fr; 1966 Oct 23; 66(10):885-907. PubMed ID: 5991635
    [No Abstract] [Full Text] [Related]

  • 9. Ocular damage in chloroquine therapy.
    Nylander U.
    Acta Ophthalmol (Copenh); 1966 Oct 23; 44(3):335-48. PubMed ID: 5953229
    [No Abstract] [Full Text] [Related]

  • 10. Monitoring patients on antimalarials: where are we now?
    Easterbrook M.
    Can J Ophthalmol; 2012 Dec 23; 47(6):465-70. PubMed ID: 23217497
    [No Abstract] [Full Text] [Related]

  • 11. [Ocular involvement in chloroquine therapy].
    Godel V, Nemet P, Stein R.
    Harefuah; 1972 Jul 16; 83(2):60-3. PubMed ID: 5068910
    [No Abstract] [Full Text] [Related]

  • 12. [Eye toxicity of antimalarial agents].
    Graña Gil J, Cabana Vázquez M, Vázquez González A, Sánchez Meizoso MO.
    An Med Interna; 2002 Apr 16; 19(4):189-91. PubMed ID: 12090061
    [Abstract] [Full Text] [Related]

  • 13. Drug-induced macular disease.
    Potts AM.
    Trans Am Acad Ophthalmol Otolaryngol; 1966 Apr 16; 70(6):1054-7. PubMed ID: 5971468
    [No Abstract] [Full Text] [Related]

  • 14. [Ocular intoxication due to chloroquine and its derivatives. Importance of functional studies, ERG and EOG. Study of a series of 400 cases (1964-71)].
    Parizot H.
    Bull Soc Belge Ophtalmol; 1972 Apr 16; 160(2):570-80. PubMed ID: 4656811
    [No Abstract] [Full Text] [Related]

  • 15. [Routine monitoring of patients treated with synthetic antimalarials].
    Douche C, Bechetoille A, Ebran JM.
    J Fr Ophtalmol; 1983 Apr 16; 6(8-9):689-95. PubMed ID: 6677659
    [Abstract] [Full Text] [Related]

  • 16. Long-term course of antimalarial maculopathy after cessation of treatment.
    Easterbrook M.
    Can J Ophthalmol; 1992 Aug 16; 27(5):237-9. PubMed ID: 1393809
    [Abstract] [Full Text] [Related]

  • 17. Ophthalmologic considerations in using antimalarials in the United States.
    Rynes RI.
    Lupus; 1996 Jun 16; 5 Suppl 1():S73-4. PubMed ID: 8803917
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature.
    Osadchy A, Ratnapalan T, Koren G.
    J Rheumatol; 2011 Dec 16; 38(12):2504-8. PubMed ID: 22002012
    [Abstract] [Full Text] [Related]

  • 20. Re: monitoring patients on antimalarials: where are we now? Author reply.
    Easterbrook M.
    Can J Ophthalmol; 2013 Aug 16; 48(4):344. PubMed ID: 23931479
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.